Related Experiment Video
Updated: Feb 3, 2026

Determining Genetic Expression Profiles in C. elegans Using Microarray and Real-time PCR
Published on: July 30, 2011
Microarray analysis of altered long non-coding RNA expression profile in liver cancer cells treated by ginsenoside
Wei-Wen Chen1, Ying-Feng Huang1, Zhi-Bing Hu1
1a Medical Laboratories, Guangzhou Twelfth People's Hospital , Guangzhou 510620 , China.
Abstract:
Microarray expression profiles of lncRNAs and mRNAs were investigated in HepG2 cells treated with 20 μg/ml ginsenoside Rh2 as well as in ginsenoside Rh2-untreated cells. Microarray analysis showed 618 upregulated lncRNAs and 161 downregulated lncRNAs in HepG2 cells treated with ginsenoside Rh2 compared with the control group. Moreover, three differentially expressed lncRNAs were validated by quantitative real-time polymerase chain reaction (qRT-PCR). This may be beneficial to patients as an anti-cancer treatment and potentially provide novel targets for HCC (hepatocellular carcinoma) therapy.
Insights
Ginsenoside Rh2 significantly altered long noncoding RNA (lncRNA) expression in liver cancer cells. This study identifies potential new targets for hepatocellular carcinoma (HCC) therapy.
Area of Science:
- Molecular Biology
- Genomics
- Cancer Research
Background:
- Hepatocellular carcinoma (HCC) is a major global health concern.
- Ginsenoside Rh2, a natural compound, shows potential anti-cancer properties.
- Understanding lncRNA roles in cancer is crucial for developing new therapies.
Purpose of the Study:
- To investigate the effect of ginsenoside Rh2 on lncRNA and mRNA expression in HepG2 cells.
- To identify differentially expressed lncRNAs in response to ginsenoside Rh2 treatment.
- To explore potential therapeutic targets for HCC.
Main Methods:
- Microarray analysis was used to profile lncRNA and mRNA expression in HepG2 cells.
- Cells were treated with 20 μg/ml ginsenoside Rh2 or left untreated.
- Quantitative real-time polymerase chain reaction (qRT-PCR) was used for validation.
Main Results:
- Ginsenoside Rh2 treatment led to significant changes in lncRNA expression.
- 618 lncRNAs were upregulated and 161 were downregulated in treated HepG2 cells.
- Three differentially expressed lncRNAs were successfully validated using qRT-PCR.
Conclusions:
- Ginsenoside Rh2 modulates lncRNA expression in hepatocellular carcinoma cells.
- The identified differentially expressed lncRNAs may serve as novel therapeutic targets for HCC.
- Further research into ginsenoside Rh2 could lead to effective anti-cancer treatments.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Cell Specific Gene Expression
What is Gene Expression?
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
RNA Editing
RNA Splicing

